Stocks and Investing
Stocks and Investing
Tue, November 8, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, November 7, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Swayampakula Ramakanth Maintained (CDXS) at Strong Buy with Decreased Target to $15 on, Nov 7th, 2022
Swayampakula Ramakanth of HC Wainwright & Co., Maintained "Codexis, Inc." (CDXS) at Strong Buy with Decreased Target from $25 to $15 on, Nov 7th, 2022.
Swayampakula has made no other calls on CDXS in the last 4 months.
There are 2 other peers that have a rating on CDXS. Out of the 2 peers that are also analyzing CDXS, 0 agree with Swayampakula's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Swayampakula
- Do Kim of "Piper Sandler" Maintained at Buy with Decreased Target to $22 on, Friday, July 15th, 2022
- Steven Mah of "Cowen & Co." Maintained at Buy with Decreased Target to $21 on, Friday, July 15th, 2022
Contributing Sources